文献速递骨质疏松与代谢性骨病创伤骨科

社区老年女性队列中衰弱进展与骨质疏松患病率——一项10年纵向研究

Progression of frailty and prevalence of osteoporosis in a community cohort of older women-a 10-year longitudinal study.
PubMed 文献 · Osteoporos Int · 2018-06-12

在社区居住的75岁女性队列(基线n=1044)中随访10年,每次访视构建衰弱指数(0.0-1.0)。衰弱评分年均增长约6-7%,较高衰弱评分相当于年龄大5-10岁;衰弱与低骨密度及死亡风险升高相关,最衰弱四分位组10年死亡率48.7% vs 最不衰弱组17.2%(p=1.7×10⁻¹⁴)。

要点

  • 最健壮(FI 0.0-0.1)比例从基线48%降至80岁25%、85岁14%。
  • 10年间仅11%的最不衰弱女性保持健壮,衰弱评分年均增长约6-7%。
  • 基线最衰弱四分位组10年死亡48.7% vs 最不衰弱组17.2%(p=1.7×10⁻¹⁴),调整BMI后衰弱与股骨颈骨密度相关(总体p=0.006)。

核心结论

  • 衰弱指数对死亡具有高度预测作用,最衰弱者在短期和长期均显示约三倍死亡风险增加。
  • 10年后仅十分之一的老年女性未出现衰弱进展。
  • 衰弱与骨质疏松存在关联。

研究设计与样本

  • 研究在旨在调查骨质疏松的OPRA队列中实施,基线为75岁女性n=1044,在80岁和85岁随访。
  • 在所有时间点基于多领域健康缺陷构建衰弱指数(评分0.0-1.0),结局为至15年的死亡率和股骨颈骨密度。

主要发现

  • 基线最健壮(FI 0.0-0.1)者占48%,80岁降至25%,85岁降至14%。
  • 10年间衰弱评分年均线性进展约6-7%,最不衰弱者中11%在10年后仍保持健壮。
  • 较高衰弱评分相当于年龄大5至10岁。
  • 基于基线衰弱评分,最高四分位组10年死亡48.7% vs 最低四分位组17.2%(p=1.7×10⁻¹⁴)。
  • 前5年死亡风险在最衰弱组最高(Q4 vs Q1;未调整HR 3.26 [1.86-5.73];p<0.001),10年时仍升高(未调整HR 3.58 [2.55-5.03];p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: In community dwelling, 75-year-old women followed 10 years, a frailty index was created at each of three visits. Frailty score increased by ~ 6-7% annually. A higher frailty score was equivalent to being 5-10 years chronologically older. Frailty was associated with low bone density and higher risk of dying. INTRODUCTION: To understand the distribution of frailty among a population-based sample of older community-dwelling women, progression over 10 years, and association with mortality and osteoporosis. METHODS: The study is performed in a cohort designed to investigate osteoporosis. The OPRA cohort consists of 75-year-old women, n = 1044 at baseline, and follow-up at age 80 and 85. A frailty index (scored from 0.0-1.0) based on deficits in health across multiple domains was created at all time-points; outcomes were mortality up to 15 years and femoral neck bone density. RESULTS: At baseline, the proportion least frail, i.e., most robust (FI 0.0-0.1) constituted 48%, dropping to 25 and 14% at age 80 and 85. On average, over 10 years, the annual linear frailty score progression was approximately 6-7%. Among the least frail, 11% remained robust over 10 years. A higher frailty score was equivalent to being 5 to 10 years older. Mortality was substantially higher in the highest quartile compared to the lowest based on baseline frailty score; after 10 years, 48.7% had died vs 17.2% (p = 1.7 × 10-14). Mortality risk over the first 5 years was highest in the frailest (Q4 vs Q1; HRunadj 3.26 [1.86-5.73]; p < 0.001) and continued to be elevated at 10 years (HRunadj 3.58 [2.55-5.03]; p < 0.001). Frailty was associated with BMD after adjusting for BMI (overall p = 0.006; Q1 vs Q4 p = 0.003). CONCLUSIONS: The frailty index was highly predictive of mortality showing a threefold increased risk of death in the frailest both in a shorter and longer perspective. Only one in ten older women escaped progression after 10 years. Frailty and osteoporosis were associated.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Bartosch P, McGuigan FE, Akesson KE, et al. Progression of frailty and prevalence of osteoporosis in a community cohort of older women-a 10-year longitudinal study. Osteoporos Int. 2018. PMID: 29947868. doi:10.1007/s00198-018-4593-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。